The landscape of genetic medicine is undergoing a seismic shift. Since its inception in 2019, prime editing—often...
In a landmark shift for clinical neurology and pharmacogenomics, the National Institute for Health and Care Excellence...
In a move that marks a significant escalation in the long-standing war over the federal 340B drug...
Breast cancer remains the most frequently diagnosed malignancy among women globally, representing a significant public health challenge...
Imagine managing a multi-billion-dollar clinical research project involving nearly six million individual data points. You have at...
In the quiet, climate-controlled chambers of the HudsonAlpha Institute for Biotechnology, the future of global agriculture is...
In the contemporary pharmaceutical landscape, the journey of a drug candidate from bench to bedside is rarely...
In an era defined by the rapid dissemination of information through social media and the burgeoning influence...
Introduction: A Port of Compassion In an era often defined by closed borders and the hardening of...
